ATE395919T1 - Prävention und behandlung von hypertonen herzerkrankungen mit den selektiven östrogenen - Google Patents
Prävention und behandlung von hypertonen herzerkrankungen mit den selektiven östrogenenInfo
- Publication number
- ATE395919T1 ATE395919T1 AT04803177T AT04803177T ATE395919T1 AT E395919 T1 ATE395919 T1 AT E395919T1 AT 04803177 T AT04803177 T AT 04803177T AT 04803177 T AT04803177 T AT 04803177T AT E395919 T1 ATE395919 T1 AT E395919T1
- Authority
- AT
- Austria
- Prior art keywords
- prevention
- treatment
- heart disease
- selective estrogens
- hypertension heart
- Prior art date
Links
- 206010020772 Hypertension Diseases 0.000 title 1
- 229940011871 estrogen Drugs 0.000 title 1
- 239000000262 estrogen Substances 0.000 title 1
- 208000019622 heart disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03090406 | 2003-11-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE395919T1 true ATE395919T1 (de) | 2008-06-15 |
Family
ID=34626396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04803177T ATE395919T1 (de) | 2003-11-26 | 2004-11-16 | Prävention und behandlung von hypertonen herzerkrankungen mit den selektiven östrogenen |
Country Status (16)
Country | Link |
---|---|
US (1) | US20050148560A1 (de) |
EP (1) | EP1689410B1 (de) |
JP (1) | JP2007512279A (de) |
AR (1) | AR046672A1 (de) |
AT (1) | ATE395919T1 (de) |
DE (1) | DE602004014020D1 (de) |
DK (1) | DK1689410T3 (de) |
ES (1) | ES2307064T3 (de) |
GT (1) | GT200400241A (de) |
PA (1) | PA8618401A1 (de) |
PE (1) | PE20050665A1 (de) |
PL (1) | PL1689410T3 (de) |
PT (1) | PT1689410E (de) |
TW (1) | TW200530263A (de) |
UY (1) | UY28630A1 (de) |
WO (1) | WO2005051401A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10027887A1 (de) | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
US7534780B2 (en) | 2004-05-21 | 2009-05-19 | Bayer Schering Pharma Aktiengesellschaft | Estradiol prodrugs |
DE102005057224A1 (de) * | 2005-11-29 | 2007-05-31 | Bayer Schering Pharma Ag | Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
TWI389917B (zh) * | 2006-04-13 | 2013-03-21 | Sigma Tau Ind Farmaceuti | 作為心血管疾病治療藥物的雄甾烷與雄甾烯之氮雜環烷基衍生物 |
TWI392682B (zh) * | 2006-04-13 | 2013-04-11 | Sigma Tau Ind Farmaceuti | 作為心血管疾病的治療藥物之雄甾烷和雄甾烯的胺基衍生物 |
WO2008091555A2 (en) | 2007-01-22 | 2008-07-31 | Gtx, Inc. | Nuclear receptor binding agents |
US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
US9623021B2 (en) * | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
EP2143432A1 (de) * | 2008-07-11 | 2010-01-13 | Bayer Schering Pharma AG | 9-Alpha-Estratrien-Derivate als ER-Beta-selektive Liganden zur Prävention und Behandlung von Darmkrebs |
WO2011079047A1 (en) * | 2009-12-23 | 2011-06-30 | Drugtech Corporation | Methods for reducing the occurrence of preterm delivery and other pregnancy-related conditions |
US9844558B1 (en) | 2015-04-30 | 2017-12-19 | Amag Pharmaceuticals, Inc. | Methods of reducing risk of preterm birth |
US10556922B2 (en) | 2015-09-29 | 2020-02-11 | Amag Pharmaceuticals, Inc. | Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10019167A1 (de) * | 2000-04-12 | 2001-10-18 | Schering Ag | Substituierte Estratriene als selektiv wirksame Estrogene |
AU2001258341B2 (en) * | 2000-04-12 | 2007-03-15 | Schering Aktiengesellschaft | 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
GB2374412A (en) * | 2001-04-11 | 2002-10-16 | Karobio Ab | Hypertension treatment and assay |
US7414043B2 (en) * | 2002-06-11 | 2008-08-19 | Schering Ag | 9-α-substituted estratrienes as selectively active estrogens |
DE10226326A1 (de) * | 2002-06-11 | 2004-01-15 | Schering Ag | 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene |
-
2004
- 2004-11-16 PL PL04803177T patent/PL1689410T3/pl unknown
- 2004-11-16 ES ES04803177T patent/ES2307064T3/es active Active
- 2004-11-16 DE DE602004014020T patent/DE602004014020D1/de active Active
- 2004-11-16 AT AT04803177T patent/ATE395919T1/de not_active IP Right Cessation
- 2004-11-16 EP EP04803177A patent/EP1689410B1/de not_active Not-in-force
- 2004-11-16 PT PT04803177T patent/PT1689410E/pt unknown
- 2004-11-16 JP JP2006540330A patent/JP2007512279A/ja active Pending
- 2004-11-16 WO PCT/EP2004/013121 patent/WO2005051401A2/en active IP Right Grant
- 2004-11-16 DK DK04803177T patent/DK1689410T3/da active
- 2004-11-23 GT GT200400241A patent/GT200400241A/es unknown
- 2004-11-23 UY UY28630A patent/UY28630A1/es not_active Application Discontinuation
- 2004-11-24 US US10/995,552 patent/US20050148560A1/en not_active Abandoned
- 2004-11-25 PA PA20048618401A patent/PA8618401A1/es unknown
- 2004-11-25 PE PE2004001154A patent/PE20050665A1/es not_active Application Discontinuation
- 2004-11-26 TW TW093136621A patent/TW200530263A/zh unknown
- 2004-11-26 AR ARP040104378A patent/AR046672A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
ES2307064T3 (es) | 2008-11-16 |
JP2007512279A (ja) | 2007-05-17 |
PT1689410E (pt) | 2008-08-18 |
EP1689410A2 (de) | 2006-08-16 |
PA8618401A1 (es) | 2005-08-04 |
DK1689410T3 (da) | 2008-09-08 |
PE20050665A1 (es) | 2005-11-02 |
DE602004014020D1 (de) | 2008-07-03 |
GT200400241A (es) | 2005-10-31 |
US20050148560A1 (en) | 2005-07-07 |
WO2005051401A2 (en) | 2005-06-09 |
WO2005051401A3 (en) | 2005-09-01 |
EP1689410B1 (de) | 2008-05-21 |
UY28630A1 (es) | 2005-06-30 |
AR046672A1 (es) | 2005-12-14 |
TW200530263A (en) | 2005-09-16 |
PL1689410T3 (pl) | 2008-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004010407D1 (de) | Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden | |
DE60108080D1 (de) | Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen | |
ATE458753T1 (de) | Methoden der verhinderung und behandlung der alzheimer'schen krankheit | |
DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
DE60108847D1 (de) | Knollenförmige klappe und stent zur behandlung von gefässrückfluss | |
ATE434444T1 (de) | Vorbeugung und behandlung von amyloidogenischen krankheiten | |
ATE369133T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
DE69940131D1 (de) | Mittel zur Behandlung von Erkrankungen der Speiseröhre | |
DE60222671D1 (de) | Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen | |
ATE448206T1 (de) | Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen | |
DE60022754D1 (de) | Diagnose und behandlung von arrhythmien | |
DE60330693D1 (de) | WuRMEBEHANDLUNGSVERFAHREN UND WuRMEBEHANDLUNGSVORRICHTUNG | |
DE60318839D1 (de) | 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten | |
ATE395919T1 (de) | Prävention und behandlung von hypertonen herzerkrankungen mit den selektiven östrogenen | |
DE602004023721D1 (de) | Zusammensetzungen und methoden für die behandlung von herzerkrankungen | |
DE60325353D1 (de) | Behandlung von mukositis | |
DE602004001134D1 (de) | Tetrazolderivate und verfahren zur behandlung von stoffwechselbedingten erkrankungen damit | |
DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
DE50114605D1 (de) | No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz | |
DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
DE602005015434D1 (de) | Mittel zur behandlung von psychoneurotischen krankheiten | |
ATE369136T1 (de) | Therapeutische behandlung | |
DE60213234D1 (de) | 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts | |
DE60103685D1 (de) | Behandlung von Poriomania | |
DE60110748D1 (de) | Behandlung von fluorkohlenstoff-beschickungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1689410 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |